Compounded methylprednisolone acetate injection under FDA investigation

  • May 24, 2013

The FDA, along with the CDC and Tennessee Board of Pharmacy, is currently investigating seven reports of adverse events associated with steroid injections compounded by Main Street Family Pharmacy, LLC, in Newbern, Tenn., according to an agency press release.

The reports are all from patients who received preservative-free methylprednisolone acetate (80 mg/mL) by injection. Clinical information about these patients is pending; at least one infection appears to be fungal, according to the release.

Full Story »

Personalize your page!

Register for Healio to get content tailored to your specialty and areas of interest. It’s FREE and only takes one minute. Register now!

More »
More »
More »
More »
[X]